Outcome and toxicity of radiotherapy combined with chemotherapy or cetuximab for head and neck cancer: Our experience in one hundred and twenty-five patients-Reference-Cited by-同舟云学术

Outcome and toxicity of radiotherapy combined with chemotherapy or cetuximab for head and neck cancer: Our experience in one hundred and twenty-five patients

Published:2013-02 Issue:1 Volume:38 Page:69-74
ISSN:1749-4478
Container-title:Clinical Otolaryngology
language:en
Short-container-title:

Author:

Beijer Y.J.,Koopman M.,Terhaard C.H.J.,Braunius W.W.,van Es R.J.J.,de Graeff A.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/coa.12002/fullpdf

Reference6 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother. Oncol.,2009

2. Radiotherapy combined with cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival;Bonner;Lancet Oncol.,2010

3. Postoperative irradiation with or without concomitant chemotherapy for high-risk squamous cell carcinoma of the head and neck;Cooper;N. Engl. J. Med.,2004

4. Postoperative irradiation with or without concomitant chemotherapy for locally advance head and neck cancer N;Bernier;Engl. J. Med.,2004

5. Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital;Langenberg;Clin. Otolaryngol.,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer;European Archives of Oto-Rhino-Laryngology;2024-09-06

2. Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan;International Journal of Environmental Research and Public Health;2023-03-03

3. Feasibility of a supervised and home‐based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy;European Journal of Cancer Care;2022-08-11

4. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer;Clinical Nutrition;2022-01

5. The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study;European Journal of Cancer;2022-01